Cite

HARVARD Citation

    Fleischmann, R. et al. (2013). SAT0129 Improved Quality of Life, Work Productivity, General Activity and Independence in Response to Subcutaneous Abatacept or Adalimumab in Rheumatoid Arthritis: Results from the Ample Trial. Annals of the rheumatic diseases. pp. A624-A625. [Online]. 
  
Back to record